⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | HDFC Value Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | HDFC MF | HDFC MF |
| Category | Equity - Value Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹848.85 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Anand Laddha | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -1.35% | 22.64% |
| 3Y | 15.36% | 30.41% |
| 5Y | 12.40% | — |
| Since Inception | 15.38% | 29.15% |
| Risk | ||
| 14.22 | 14.07 | |
| 1.01 | 0.59 | |
| 0.61 | 1.59 | |
| 4.79 | 21.67 | |
| 1.17 | 3.48 | |
| -12.22% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.11% | 1.03% |
| Exit Load | 1% on or before 1Y, Nil after 1Y | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹100 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
HDFC MF96%
HDFC MF96%
3.8%Only 3.8% of holdings by weight are common between HDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingHDFC MFHDFC MF
Sun Pharmaceutical Industries Ltd.2.20%8.28%
Divi's Laboratories Ltd.1.62%9.39%
Category context: Equity vs Equity. Open the full Screener →